BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 201577)

  • 21. Strategies for preventing heroin overdose.
    Sporer KA
    BMJ; 2003 Feb; 326(7386):442-4. PubMed ID: 12595388
    [No Abstract]   [Full Text] [Related]  

  • 22. Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
    Holtzman SG
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1033-41. PubMed ID: 12604679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drug-dependent patients. Emergency and non-emergency treatment in hospital and ambulatory environments].
    Ravizza L
    Minerva Psichiatr; 1979; 20(4):217-25. PubMed ID: 550862
    [No Abstract]   [Full Text] [Related]  

  • 24. A study of the effectiveness of naltrexone in preventing recurrence of methadone poisoning in opioid-naive children.
    Gholami N; Farnaghi F; Saberi M; Zamani N; McDonald R; Hassanian-Moghaddam H
    Drug Alcohol Depend; 2021 Feb; 219():108425. PubMed ID: 33291028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regarding naltrexone for probationers and parolees.
    Stancliff S
    J Subst Abuse Treat; 2007 Mar; 32(2):217-8; author reply 218-9. PubMed ID: 17306730
    [No Abstract]   [Full Text] [Related]  

  • 26. Methadone maintenance vs. implantable naltrexone treatment in the pregnant heroin user.
    Hulse GK; O'Neil G; Arnold-Reed DE
    Int J Gynaecol Obstet; 2004 May; 85(2):170-1. PubMed ID: 15099783
    [No Abstract]   [Full Text] [Related]  

  • 27. Opiate antagonists and 'blockers'.
    Murphree HB
    Am Fam Physician; 1973 Apr; 7(4):136-7. PubMed ID: 4694336
    [No Abstract]   [Full Text] [Related]  

  • 28. Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey.
    Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):245-52. PubMed ID: 2164093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospects, problems, side effects, and safety of narcotic antagonists.
    Resnick RB
    Int J Addict; 1977 Oct; 12(7):863-7. PubMed ID: 591144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mu opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the mu opioid receptor.
    Morgan D; Picker MJ
    Psychopharmacology (Berl); 1998 Nov; 140(1):20-8. PubMed ID: 9862398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Historical perspective on the chemistry and development of naltrexone.
    Archer S
    NIDA Res Monogr; 1981; 28():3-10. PubMed ID: 6791011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic treatments for heroin and cocaine dependence.
    Kleber HD
    Am J Addict; 2003; 12(s2):S5-S18. PubMed ID: 12857659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclazocine and methadone in narcotic addiction.
    Freedman AM; Fink M; Sharoff R; Zaks A
    JAMA; 1967 Oct; 202(3):191-4. PubMed ID: 6072354
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacotherapy of narcotic dependence.
    Maykut MO
    Prog Neuropsychopharmacol; 1977; 1(1-2):31-49. PubMed ID: 31641
    [No Abstract]   [Full Text] [Related]  

  • 35. Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment.
    Tait RJ; Ngo HT; Hulse GK
    J Subst Abuse Treat; 2008 Sep; 35(2):116-24. PubMed ID: 17931824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naltrexone-assisted rapid methadone discontinuation: a pilot study.
    Camarasa X; Khazaal Y; Besson J; Zullino DF
    Eur Addict Res; 2007; 13(1):20-4. PubMed ID: 17172775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methadone and naltrexone in the treatment of heroin dependence.
    Greenstein RA; Resnick RB; Resnick E
    Psychiatr Clin North Am; 1984 Dec; 7(4):671-9. PubMed ID: 6522309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological approaches to the treatment of morphine-type dependence.
    Halbach H
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):6-12. PubMed ID: 1165143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A unit for delivering multiple drug treatment and prevention services.
    Hosp Community Psychiatry; 1975 Oct; 26(10):663-6. PubMed ID: 1201850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Surprising conclusion by the SBU concerning the benefits of naltrexone in the treatment of heroin dependence].
    Heilig M
    Lakartidningen; 2002 Jan; 99(3):200-4. PubMed ID: 11838078
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.